Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms DC-E39, E39 peptide vaccine, FBP + [4] |
Target- |
Mechanism Immunostimulants, T lymphocytes stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | US | - | |
Breast Cancer | Phase 2 | - | - | |
Breast Cancer | Phase 2 | - | - | |
Breast Cancer | Phase 2 | - | - | |
Endometrial Carcinoma | Phase 2 | US | - | |
Endometrial Carcinoma | Phase 2 | - | - | |
Endometrial Carcinoma | Phase 2 | - | - | |
Endometrial Carcinoma | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | US | - | |
Ovarian Cancer | Phase 2 | - | - |
Phase 1 | 51 | gunoklloff(fivsuijqds) = htzufmjbsg yrnafevclw (qrecfmjwmo ) | Positive | 15 Jul 2016 | |||
gunoklloff(fivsuijqds) = dlufdrtmpn yrnafevclw (qrecfmjwmo ) | |||||||
Phase 2 | 47 | Vaccine Group (VG) | pwynpwcgyz(ccnqziqpfs) = aheqmfygyu zqykltpbfy (hpabdothxp ) View more | Positive | 06 Nov 2014 | ||
folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) (Control Group (CG)) | pwynpwcgyz(ccnqziqpfs) = wihdndwghu zqykltpbfy (hpabdothxp ) View more | ||||||
Phase 1 | 25 | E39 vaccine 100mcg | jzkgfdwkeg(biamtxmgnl) = qeeqitsgfg mrwdfsecjf (akbwfhilvf ) View more | Positive | 07 Nov 2013 | ||
E39 vaccine 500mcg | jzkgfdwkeg(biamtxmgnl) = ukiymxsnsx mrwdfsecjf (akbwfhilvf ) View more |